Business Daily.
.
The Times Real Estate
A+ R A-

imageTHOUSAND OAKS, Calif., Sept. 11, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the publication of a biomarker analysis of Vectibix® (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with......


Page 1687 of 1799

Business Daily Media